Results 91 to 100 of about 2,162,553 (329)

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

open access: yes, 1990
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1284/thumbnail ...

core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Re-engaging with arts and cultural activities at the Life Rooms: ‘It’s given me spring’

open access: yesBMC Complementary Medicine and Therapies
Background Mersey Care NHS Foundation Trust’s Life Rooms initiative is an established and successful model of integrating arts and culture within NHS provision.
Joanne Worsley   +2 more
doaj   +1 more source

Does Ownership Matter for Medical System Performance? Evidence From a Natural Experiment in Suqian, China

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2020
There has long been a major policy debate on the role of hospital ownership (private vs public) in medical system performance. China’s health care delivery system is mainly a public system. In 2000, a full privatization reform was implemented in the city
Gordon G. Liu PhD   +4 more
doaj   +1 more source

Talking together : consumer communities in healthcare [PDF]

open access: yes, 2004
Consumer involvement in computer mediated communities (CMCs) is increasing particularly in high involvement services such as healthcare. This paper examines the role of CMCs as providers of patient information and support and the subsequent effect on the
Hogg, Gillian   +2 more
core   +1 more source

Digital Apparel Try-Ons: A Technological Odyssey into the World of Virtual Dressing Rooms and Consumer Engagement

open access: yesInternational Research Journal on Advanced Engineering and Management (IRJAEM)
This individual can now enjoy internet shopping whenever they want and from anywhere in the world thanks to the invention of smartphones and tablets. Online shopping has unquestionably taken the place of conventional methods for purchasing apparel and ...
Parul Kakade   +4 more
semanticscholar   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Barnes Hospital Record [PDF]

open access: yes, 1963
https://digitalcommons.wustl.edu/bjc_barnes_record/1187/thumbnail ...

core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy